交易所：Frankfurt ，行业：生物技术，股市 - 报价与价格
包含价格、市值、市盈率和每股收益的所有股票清单
Frankfurt (648)
- {{item.name}}
- 所有交流
- Amsterdam (3)
- ASX (58)
- Brussels (7)
- BSE (9)
- Canadian Sec (30)
- Cboe CA (4)
- Copenhagen (6)
- Dusseldorf (1)
- Frankfurt (648)
- Helsinki (4)
- HKSE (46)
- IOB (25)
- Irish (1)
- Istanbul (1)
- KOSDAQ (2)
- KSE (10)
- LSE (44)
- MCE (4)
- MCX (2)
- Mexico (28)
- Milan (4)
- Munich (27)
- NasdaqCM (289)
- NasdaqGM (143)
- NasdaqGS (218)
- NSE (10)
- NYSE (11)
- NYSE American (18)
- NYSEArca (1)
- NZSE (1)
- Oslo (14)
- OTC Markets EXMKT (119)
- OTC Markets OTCPK (134)
- OTC Markets OTCQB (33)
- OTC Markets OTCQX (7)
- Other OTC (39)
- Paris (41)
- São Paulo (16)
- Shanghai (47)
- Shenzhen (45)
- Stockholm (70)
- Stuttgart (39)
- Swiss (11)
- Taipei Exchange (59)
- Taiwan (8)
- Tel Aviv (19)
- Thailand (2)
- Tokyo (37)
- Toronto (19)
- TSXV (30)
- Vienna (16)
- Warsaw (9)
- XETRA (23)
所有版块
- {{item.name}}
- 所有版块
- 医疗保健 (648)
生物技术 (648)
- {{item.name}}
- 所有行业
- 农业投入 (36)
- 建筑材料 (62)
- 化学品 (65)
- 特种化学品 (177)
- 木材和木材生产 (23)
- 纸和纸制品 (37)
- 铝 (20)
- 铜 (47)
- 其他工业金属和采矿 (614)
- 金 (366)
- 银 (21)
- 其他贵金属和采矿 (140)
- 炼焦煤 (15)
- 钢 (86)
- 汽车和卡车经销商 (39)
- 汽车制造商 (82)
- 汽车零部件 (149)
- 休闲车 (24)
- 家具、固定装置和器具 (53)
- 住宅建筑 (54)
- 纺织品制造 (24)
- 服装制造 (52)
- 鞋类和配件 (28)
- 包装和容器 (63)
- 个人服务 (23)
- 餐厅 (83)
- 服装零售 (55)
- 百货商店 (36)
- 家居装饰零售 (23)
- 奢侈品 (36)
- 互联网零售 (96)
- 专业零售 (97)
- 博彩 (52)
- 休闲 (70)
- 住宿 (37)
- 度假村和赌场 (43)
- 旅行服务 (34)
- 资产管理 (271)
- 银行 – 多元化 (56)
- 银行 – 区域 (386)
- 抵押贷款融资 (22)
- 资本市场 (136)
- 金融数据和股票交易所 (33)
- 保险 – 人寿 (47)
- 保险 – 财产和意外伤害 (49)
- 保险 – 再保险 (14)
- 保险 – 专业 (23)
- 保险经纪人 (15)
- 保险 – 多元化 (48)
- 空壳公司 (63)
- 金融集团 (12)
- 信贷服务 (113)
- 房地产 – 开发 (131)
- 房地产服务 (153)
- 房地产 – 多元化 (40)
- 房地产投资信托 – 医疗保健设施 (15)
- 房地产投资信托 – 酒店和汽车旅馆 (12)
- 房地产投资信托 – 工业 (21)
- 房地产投资信托 – 办公室 (27)
- 房地产投资信托 – 住宅 (17)
- 房地产投资信托 – 零售 (38)
- 房地产投资信托 – 抵押贷款 (29)
- 房地产投资信托 – 专业 (15)
- 房地产投资信托 – 多元化 (31)
- 酒水 – 啤酒制造商 (34)
- 酒水 – 酒庄和酿酒厂 (40)
- 酒水 – 非酒精类 (28)
- 糖果商 (12)
- 农产品 (78)
- 家用和个人用品 (70)
- 包装食品 (185)
- 教育和培训服务 (42)
- 折扣店 (21)
- 食品配送 (35)
- 食品杂货店 (41)
- 烟草 (21)
- 生物技术 (648)
- 药品制造商 – 仿制药 (45)
- 药品制造商 – 特药和仿制药 (277)
- 医疗保健计划 (9)
- 医疗保健设施 (93)
- 医药零售商 (21)
- 健康信息服务 (81)
- 医疗器械 (202)
- 医疗仪器和用品 (106)
- 诊断和研究 (102)
- 医药分销 (22)
- 公用事业 – 独立发电公司 (27)
- 公用事业 – 可再生能源 (112)
- 公用事业 – 管制水 (33)
- 公用事业 – 管制电 (69)
- 公用事业 – 管制天然气 (38)
- 公用事业 – 多元化 (44)
- 电信服务 (170)
- 广告代理机构 (92)
- 出版 (36)
- 广播 (40)
- 娱乐 (110)
- 互联网内容和信息 (90)
- 电子游戏和多媒体 (117)
- 石油和天然气钻探 (15)
- 石油和天然气勘探与生产 (257)
- 石油和天然气一体化 (46)
- 石油和天然气中游 (41)
- 石油和天然气精炼与营销 (51)
- 石油和天然气设备与服务 (103)
- 热能煤 (39)
- 铀 (39)
- 航空航天与国防 (112)
- 专业商业服务 (99)
- 咨询服务 (29)
- 出租和租赁服务 (42)
- 安全与保护服务 (39)
- 人事与就业服务 (41)
- 综合性企业 (96)
- 工程与建筑 (188)
- 基础设施运营 (23)
- 建筑产品和设备 (74)
- 农用和重型工程机械 (72)
- 工业分销 (49)
- 商业设备和用品 (16)
- 特种工业机械 (245)
- 金属加工 (36)
- 污染与处理控制 (50)
- 工具和配件 (29)
- 电气设备与零件 (101)
- 机场和航空服务 (27)
- 航空公司 (54)
- 铁路 (42)
- 海运 (93)
- 货车运输 (16)
- 综合货运与物流 (49)
- 废物管理 (56)
- 信息技术服务 (193)
- 软件 – 应用程序 (387)
- 软件 – 基础设施 (190)
- 通信设备 (112)
- 计算机硬件 (62)
- 消费电子产品 (48)
- 电子元器件 (95)
- 电子和计算机分销 (25)
- 科学技术仪器 (53)
- 半导体设备与材料 (58)
- 半导体 (91)
- 太阳能 (50)
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 |
|---|
| 名称 名称 | 价格 价格 |
24h% 7d chart 24h% & 7d |
市值 市值 | 交易量 交易量 | 低24小时 | 高24小时 | 市值 | 市盈率 | 每股收益 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Sino Biopharmaceutical Limited SMZ1.F | $0.56 0.61 USD |
-2.3
|
$10.73B 11.73B USD | $2.7K 2.95K USD | $0.56 0.61 USD | $0.56 0.61 USD | $10.73B 11.73B USD | 56.06 | $0.01 0.01 USD | |
| CureVac N.V. 5CV.F | $4.6 5.03 USD |
-0.65
|
$1.04B 1.13B USD | $14.55K 15.9K USD | $4.57 5 USD | $4.63 5.06 USD | $1.04B 1.13B USD | 5.60 | $0.82 0.9 USD | |
| Valneva SE AYJ.F | $2.44 2.66 USD |
+2.78
|
$414.28M 452.86M USD | $1K 1.09K USD | $2.41 2.64 USD | $2.44 2.66 USD | $414.28M 452.86M USD | 0 | -$0.58 -0.6 USD | |
| Ocugen, Inc. 2H51.F | $0.9499 1.04 USD |
+12.61
|
$277.43M 303.27M USD | $2.93K 3.2K USD | $0.8699 0.95 USD | $0.9499 1.04 USD | $277.43M 303.27M USD | 0 | -$0.19 -0.2 USD | |
| Abliva AB (publ) NTP.F | $0.04 0.04 USD |
0
|
$64.47M 70.47M USD | $4K 4.37K USD | $0.02999 0.03 USD | $0.04 0.04 USD | $64.47M 70.47M USD | 0 | -$0.01 -0.01 USD | |
| Immunic, Inc. 10VA.F | $0.5999 0.66 USD |
-3.23
|
$57.49M 62.84M USD | $900 983.82 USD | $0.5999 0.66 USD | $0.5999 0.66 USD | $57.49M 62.84M USD | 0 | -$0.84 -0.9 USD | |
| Alterity Therapeutics Limited PBN.F | $0.004 0.0043 USD |
0
|
$49.79M 54.42M USD | $480K 524.7K USD | $0.004 0.0043 USD | $0.004 0.0043 USD | $49.79M 54.42M USD | 0 | $0 0 USD | |
| Defence Therapeutics Inc. DTC.F | $0.5 0.55 USD |
+8.46
|
$27.42M 29.97M USD | $6.3K 6.89K USD | $0.4699 0.51 USD | $0.5 0.55 USD | $27.42M 29.97M USD | 0 | -$0.05 -0.05 USD | |
| Active Biotech AB (publ) BTPC.F | $0.01 0.02 USD |
-15.34
|
$16.98M 18.56M USD | $50K 54.66K USD | $0.01 0.02 USD | $0.01 0.02 USD | $16.98M 18.56M USD | 0 | -$0.01 -0.01 USD | |
| BioVaxys Technology Corp. 5LB.F | $0.01 0.01 USD |
0
|
$7.43M 8.12M USD | $23K 25.14K USD | $0.01 0.01 USD | $0.01 0.01 USD | $7.43M 8.12M USD | 0 | -$0.01 -0.01 USD | |
| Glow Lifetech Corp. 9DO.F | $0.02 0.02 USD |
0
|
$4.85M 5.3M USD | $5K 5.47K USD | $0.02 0.02 USD | $0.02 0.02 USD | $4.85M 5.3M USD | 0 | -$0.02 -0.02 USD | |
| BioSenic S.A. BT1.F | $0.0025 0.0027 USD |
-3.85
|
$2.49M 2.72M USD | $200K 218.63K USD | $0.0025 0.0027 USD | $0.0025 0.0027 USD | $2.49M 2.72M USD | 0 | -$0.04 -0.04 USD | |
| Medigene AG MDG1.F | $0.13 0.14 USD |
0
|
$1.98M 2.17M USD | $24 26.24 USD | $0.13 0.14 USD | $0.13 0.14 USD | $1.98M 2.17M USD | 0 | -$1.2 -1.3 USD | |
| Novo Nordisk A/S NOVA.F | $61.2 66.9 USD |
+2
|
$257.91B 281.93B USD | $2.44K 2.66K USD | $60.2 65.81 USD | $61.5 67.23 USD | $257.91B 281.93B USD | 18.32 | $3.34 3.65 USD | |
| Vertex Pharmaceuticals Incorporated VX1.F | $383.45 419.16 USD |
-0.08
|
$99.02B 108.24B USD | $275 300.61 USD | $383.45 419.16 USD | $383.45 419.16 USD | $99.02B 108.24B USD | 0 | -$3.34 -3.6 USD | |
| CSL Limited CSJ.F | $133.56 146 USD |
+0.66
|
$65.54B 71.64B USD | $5 5.47 USD | $133.56 146 USD | $133.56 146 USD | $65.54B 71.64B USD | 28.11 | $4.75 5.19 USD | |
| CSL Limited CSJA.F | $66 72.15 USD |
0
|
$64.86B 70.9B USD | $5 5.47 USD | $66 72.15 USD | $66 72.15 USD | $64.86B 70.9B USD | 27.61 | $2.39 2.61 USD | |
| Seagen Inc. SGT.F | $208.6 228.03 USD |
0
|
$39.36B 43.02B USD | $0 0 USD | $0 0 USD | $0 0 USD | $39.36B 43.02B USD | 0 | $0 0 USD | |
| Alnylam Pharmaceuticals, Inc. DUL.F | $269.1 294.16 USD |
+0.11
|
$35.26B 38.54B USD | $88 96.2 USD | $269.1 294.16 USD | $269.1 294.16 USD | $35.26B 38.54B USD | 0 | -$1.84 -2.01 USD | |
| UCB SA UNC.F | $167.95 183.59 USD |
+4.87
|
$31.92B 34.89B USD | $7 7.65 USD | $167.5 183.1 USD | $167.5 183.1 USD | $31.92B 34.89B USD | 30.81 | $5.45 5.96 USD | |
| UCB SA UNC0.F | $82.5 90.18 USD |
+5.1
|
$31.46B 34.39B USD | $50 54.66 USD | $82.5 90.18 USD | $82.5 90.18 USD | $31.46B 34.39B USD | 30.10 | $2.74 3 USD | |
| argenx SE 1AE.F | $474.9 519.13 USD |
+1.28
|
$29B 31.7B USD | $2 2.19 USD | $474.9 519.13 USD | $474.9 519.13 USD | $29B 31.7B USD | 33.00 | $14.39 15.73 USD | |
| argenx SE 1AEA.F | $462 505.03 USD |
-0.43
|
$28.89B 31.58B USD | $12 13.12 USD | $462 505.03 USD | $462 505.03 USD | $28.89B 31.58B USD | 32.71 | $14.12 15.44 USD | |
| BeOne Medicines Ltd. 49BA.F | $230 251.42 USD |
+4.55
|
$27.29B 29.83B USD | $6 6.56 USD | $230 251.42 USD | $230 251.42 USD | $27.29B 29.83B USD | 0 | -$3.16 -3.4 USD | |
| BeOne Medicines Ltd. 49B.F | $16.6 18.15 USD |
0
|
$25.73B 28.13B USD | $0 0 USD | $0 0 USD | $0 0 USD | $25.73B 28.13B USD | 0 | $0 0 USD | |
| BioNTech SE 22UA.F | $90.7 99.15 USD |
+2.6
|
$21.8B 23.83B USD | $153 167.25 USD | $90.15 98.55 USD | $90.9 99.37 USD | $21.8B 23.83B USD | 0 | -$3.32 -3.6 USD | |
| Insmed Incorporated IM8N.F | $92.5 101.11 USD |
+2.78
|
$18.73B 20.47B USD | $88 96.2 USD | $90 98.38 USD | $92.5 101.11 USD | $18.73B 20.47B USD | 0 | -$4.93 -5.3 USD | |
| Royalty Pharma plc RPD.F | $30.4 33.23 USD |
+0.9
|
$17.82B 19.48B USD | $150 163.97 USD | $30.4 33.23 USD | $30.4 33.23 USD | $17.82B 19.48B USD | 14.54 | $2.09 2.28 USD | |
| Innovent Biologics, Inc. 6IB.F | $9.15 10 USD |
+5.78
|
$15.6B 17.05B USD | $1K 1.09K USD | $8.75 9.56 USD | $9.15 10 USD | $15.6B 17.05B USD | 0 | -$0.01 -0.01 USD | |
| Verona Pharma plc I9SA.F | $84.2 92.04 USD |
+2.18
|
$11.49B 12.56B USD | $86 94.01 USD | $82 89.64 USD | $86.6 94.67 USD | $11.49B 12.56B USD | 0 | -$1.74 -1.9 USD | |
| WuXi Biologics (Cayman) Inc. 1FW1.F | $5.4 5.9 USD |
+0.93
|
$11.47B 12.54B USD | $208 227.37 USD | $5.4 5.9 USD | $5.4 5.9 USD | $11.47B 12.54B USD | 30.00 | $0.18 0.2 USD | |
| WuXi Biologics (Cayman) Inc. 1FW2.F | $2.73 2.99 USD |
+1.2
|
$11.47B 12.53B USD | $521 569.52 USD | $2.73 2.99 USD | $2.73 2.99 USD | $11.47B 12.53B USD | 30.34 | $0.09 0.1 USD | |
| Exelixis, Inc. EX9.F | $38.58 42.17 USD |
0
|
$11.35B 12.41B USD | $30 32.79 USD | $37.17 40.63 USD | $38.58 42.17 USD | $11.35B 12.41B USD | 22.30 | $1.73 1.89 USD | |
| Incyte Corporation ICY.F | $57.86 63.25 USD |
-2.06
|
$11.2B 12.24B USD | $1.36K 1.49K USD | $57.86 63.25 USD | $57.86 63.25 USD | $11.2B 12.24B USD | 340.35 | $0.17 0.19 USD | |
| United Therapeutics Corporation UTH.F | $247.6 270.66 USD |
-0.68
|
$11.17B 12.21B USD | $80 87.45 USD | $247.6 270.66 USD | $247.6 270.66 USD | $11.17B 12.21B USD | 11.18 | $22.13 24.19 USD | |
| Akeso, Inc. 4RY.F | $10.6 11.59 USD |
+1.92
|
$10.14B 11.08B USD | $100 109.31 USD | $10.5 11.48 USD | $10.6 11.59 USD | $10.14B 11.08B USD | 0 | -$0.07 -0.07 USD | |
| Ascendis Pharma A/S A71.F | $152 166.16 USD |
0
|
$9.56B 10.45B USD | $1 1.09 USD | $152 166.16 USD | $152 166.16 USD | $9.56B 10.45B USD | 0 | -$5.62 -6.1 USD | |
| BioMarin Pharmaceutical Inc. BM8.F | $46.63 50.97 USD |
-0.79
|
$8.94B 9.78B USD | $20 21.86 USD | $46.63 50.97 USD | $46.63 50.97 USD | $8.94B 9.78B USD | 19.59 | $2.38 2.6 USD | |
| Moderna, Inc. 0QF.F | $22.65 24.75 USD |
+3.47
|
$8.76B 9.57B USD | $70 76.52 USD | $22.19 24.25 USD | $22.65 24.75 USD | $8.76B 9.57B USD | 0 | -$7.77 -8.4 USD | |
| ImmunoGen, Inc. IMU.F | $28.74 31.42 USD |
0
|
$8.08B 8.83B USD | $0 0 USD | $0 0 USD | $0 0 USD | $8.08B 8.83B USD | 0 | $0 0 USD | |
| BridgeBio Pharma, Inc. 2CL.F | $36.45 39.84 USD |
+1.31
|
$7.4B 8.09B USD | $35 38.26 USD | $36.45 39.84 USD | $36.45 39.84 USD | $7.4B 8.09B USD | 0 | -$2.95 -3.2 USD | |
| Blueprint Medicines Corporation 2L9.F | $110.7 121.01 USD |
+0.64
|
$7.31B 7.99B USD | $135 147.57 USD | $110.7 121.01 USD | $110.7 121.01 USD | $7.31B 7.99B USD | 0 | -$2.17 -2.3 USD | |
| Corcept Therapeutics Incorporated HTD.F | $63.8 69.74 USD |
+4.18
|
$7.12B 7.78B USD | $11 12.02 USD | $63.8 69.74 USD | $63.8 69.74 USD | $7.12B 7.78B USD | 63.79 | $1 1.09 USD | |
| Roivant Sciences Ltd. 87S.F | $9.87 10.79 USD |
+1.92
|
$6.93B 7.57B USD | $600 655.88 USD | $9.87 10.79 USD | $9.88 10.8 USD | $6.93B 7.57B USD | 0 | -$0.65 -0.7 USD | |
| Bio-Techne Corporation TE1.F | $42.2 46.13 USD |
-0.94
|
$6.67B 7.29B USD | $50 54.66 USD | $42.2 46.13 USD | $42.2 46.13 USD | $6.67B 7.29B USD | 58.61 | $0.72 0.79 USD | |
| Revolution Medicines, Inc. 42Z.F | $34.2 37.39 USD |
0
|
$6.45B 7.05B USD | $16 17.49 USD | $34.2 37.39 USD | $34.2 37.39 USD | $6.45B 7.05B USD | 0 | -$3.51 -3.8 USD | |
| Sirius XM Holdings Inc. R 3HY.F | $18.75 20.5 USD |
-1.32
|
$6.39B 6.98B USD | $106 115.87 USD | $18.75 20.5 USD | $18.75 20.5 USD | $6.39B 6.98B USD | 0 | -$4.37 -4.7 USD | |
| 3SBio Inc. 83B.F | $2.48 2.71 USD |
+2.48
|
$6.22B 6.79B USD | $3.97K 4.34K USD | $2.4 2.62 USD | $2.48 2.71 USD | $6.22B 6.79B USD | 24.80 | $0.1 0.11 USD | |
| Financière de Tubize SA FTD.F | $131.4 143.64 USD |
+6.31
|
$5.85B 6.39B USD | $70 76.52 USD | $131.4 143.64 USD | $131.4 143.64 USD | $5.85B 6.39B USD | 64.72 | $2.03 2.22 USD | |
| Halozyme Therapeutics, Inc. RV7.F | $45.58 49.83 USD |
-0.18
|
$5.62B 6.14B USD | $40 43.73 USD | $45.58 49.83 USD | $45.68 49.93 USD | $5.62B 6.14B USD | 13.85 | $3.29 3.6 USD | |
| ALK-Abelló A/S 4AJ0.F | $24.78 27.09 USD |
+0.49
|
$5.58B 6.1B USD | $141 154.13 USD | $24.78 27.09 USD | $24.98 27.31 USD | $5.58B 6.1B USD | 45.05 | $0.55 0.6 USD | |
| Jazz Pharmaceuticals plc J7Z.F | $91.8 100.35 USD |
+0.07
|
$5.55B 6.07B USD | $6 6.56 USD | $91.8 100.35 USD | $91.8 100.35 USD | $5.55B 6.07B USD | 14.10 | $6.51 7.12 USD | |
| Madrigal Pharmaceuticals, Inc. YDO1.F | $243.1 265.74 USD |
-0.21
|
$5.4B 5.9B USD | $17 18.58 USD | $243.1 265.74 USD | $243.1 265.74 USD | $5.4B 5.9B USD | 0 | -$15.75 -17.2 USD | |
| Legend Biotech Corporation 9LB.F | $29.2 31.92 USD |
+0.69
|
$5.38B 5.88B USD | $140 153.04 USD | $29.2 31.92 USD | $29.2 31.92 USD | $5.38B 5.88B USD | 0 | -$1.04 -1.1 USD | |
| TG Therapeutics, Inc. NKB2.F | $31.67 34.61 USD |
+2.48
|
$5.3B 5.8B USD | $50 54.66 USD | $31.67 34.61 USD | $31.67 34.61 USD | $5.3B 5.8B USD | 150.78 | $0.21 0.23 USD | |
| Ionis Pharmaceuticals, Inc. ISI.F | $32.39 35.41 USD |
+0.4
|
$5.3B 5.79B USD | $235 256.89 USD | $32.39 35.41 USD | $32.39 35.41 USD | $5.3B 5.79B USD | 0 | -$2.57 -2.8 USD | |
| Abcam plc A8C3.F | $11.7 12.79 USD |
0
|
$4.82B 5.27B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.82B 5.27B USD | 0 | $0 0 USD | |
| Axsome Therapeutics, Inc. 19X.F | $87 95.1 USD |
+1
|
$4.36B 4.76B USD | $71 77.61 USD | $87 95.1 USD | $87 95.1 USD | $4.36B 4.76B USD | 0 | -$5.07 -5.5 USD | |
| Alpine Immune Sciences, Inc. 34LA.F | $59 64.49 USD |
0
|
$4.1B 4.48B USD | $0 0 USD | $0 0 USD | $0 0 USD | $4.1B 4.48B USD | 0 | $0 0 USD | |
| Asymchem Laboratories (Tianjin) Co., Ltd. 7K90.F | $8.1 8.85 USD |
+2.53
|
$3.84B 4.2B USD | $200 218.63 USD | $8.05 8.8 USD | $8.1 8.85 USD | $3.84B 4.2B USD | 23.82 | $0.34 0.37 USD | |
| Mirati Therapeutics, Inc. 26M.F | $53.3 58.26 USD |
0
|
$3.79B 4.14B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.79B 4.14B USD | 0 | $0 0 USD | |
| Akero Therapeutics, Inc. 0K4.F | $46.63 50.97 USD |
-0.28
|
$3.72B 4.06B USD | $150 163.97 USD | $46.63 50.97 USD | $46.63 50.97 USD | $3.72B 4.06B USD | 0 | -$3.29 -3.5 USD | |
| Vaxcyte, Inc. 5VA.F | $27.2 29.73 USD |
+0.74
|
$3.7B 4.05B USD | $280 306.08 USD | $27.2 29.73 USD | $27.2 29.73 USD | $3.7B 4.05B USD | 0 | -$3.52 -3.8 USD | |
| Genscript Biotech Corporation G51.F | $1.61 1.76 USD |
+0.12
|
$3.69B 4.04B USD | $2.77K 3.03K USD | $1.61 1.76 USD | $1.61 1.76 USD | $3.69B 4.04B USD | 0 | -$0.07 -0.07 USD | |
| Zai Lab Limited 1ZL.F | $32 34.98 USD |
+4.58
|
$3.67B 4.02B USD | $230 251.42 USD | $32 34.98 USD | $32 34.98 USD | $3.67B 4.02B USD | 0 | -$2.14 -2.3 USD | |
| Krystal Biotech, Inc. 4KB.F | $118.6 129.65 USD |
+4.22
|
$3.62B 3.95B USD | $190 207.7 USD | $118.6 129.65 USD | $118.6 129.65 USD | $3.62B 3.95B USD | 32.67 | $3.63 3.97 USD | |
| Rhythm Pharmaceuticals, Inc. 1RV.F | $53.5 58.48 USD |
0
|
$3.54B 3.87B USD | $20 21.86 USD | $53.5 58.48 USD | $53.5 58.48 USD | $3.54B 3.87B USD | 0 | -$2.37 -2.5 USD | |
| CymaBay Therapeutics, Inc. C0I.F | $29.8 32.58 USD |
0
|
$3.43B 3.75B USD | $0 0 USD | $0 0 USD | $0 0 USD | $3.43B 3.75B USD | 0 | $0 0 USD | |
| Cytokinetics, Incorporated KK3A.F | $28 30.61 USD |
+0.72
|
$3.41B 3.73B USD | $150 163.97 USD | $28 30.61 USD | $28 30.61 USD | $3.41B 3.73B USD | 0 | -$4.6 -5.02 USD | |
| Merus N.V. 2GH.F | $44.4 48.54 USD |
-1.78
|
$3.37B 3.68B USD | $106 115.87 USD | $44.2 48.32 USD | $44.4 48.54 USD | $3.37B 3.68B USD | 0 | -$3.6 -3.9 USD | |
| ACADIA Pharmaceuticals Inc. DR6.F | $19.32 21.11 USD |
-1.23
|
$3.23B 3.53B USD | $100 109.31 USD | $19.32 21.11 USD | $19.32 21.11 USD | $3.23B 3.53B USD | 16.09 | $1.2 1.31 USD | |
| Camurus AB (publ) 7CA.F | $54.25 59.3 USD |
+4.33
|
$3.22B 3.52B USD | $50 54.66 USD | $54.25 59.3 USD | $54.25 59.3 USD | $3.22B 3.52B USD | 65.36 | $0.83 0.91 USD | |
| Ultragenyx Pharmaceutical Inc. UP0.F | $31.8 34.76 USD |
0
|
$3.01B 3.29B USD | $48 52.47 USD | $31.8 34.76 USD | $31.8 34.76 USD | $3.01B 3.29B USD | 0 | -$5.13 -5.6 USD | |
| Ascentage Pharma Group International 36X.F | $8.35 9.13 USD |
+5.7
|
$2.97B 3.25B USD | $174 190.21 USD | $8.25 9.02 USD | $8.35 9.13 USD | $2.97B 3.25B USD | 0 | -$0.16 -0.1 USD | |
| Laboratorios Farmaceuticos Rovi, S.A. 41L.F | $54.85 59.96 USD |
+0.09
|
$2.81B 3.07B USD | $75 81.99 USD | $54.85 59.96 USD | $54.85 59.96 USD | $2.81B 3.07B USD | 19.80 | $2.77 3.03 USD | |
| Scholar Rock Holding Corporation 2QK.F | $28.6 31.26 USD |
-2.05
|
$2.75B 3B USD | $125 136.64 USD | $28.6 31.26 USD | $28.6 31.26 USD | $2.75B 3B USD | 0 | -$2.17 -2.3 USD | |
| MorphoSys AG MOR2.F | $16.8 18.36 USD |
0
|
$2.61B 2.85B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.61B 2.85B USD | 0 | $0 0 USD | |
| Morphic Holding, Inc. 31Y.F | $50 54.66 USD |
0
|
$2.6B 2.84B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.6B 2.84B USD | 0 | $0 0 USD | |
| MorphoSys AG MOR.F | $67.8 74.11 USD |
0
|
$2.55B 2.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.55B 2.79B USD | 0 | $0 0 USD | |
| Viking Therapeutics, Inc. 1VT.F | $22.43 24.51 USD |
+6.79
|
$2.52B 2.75B USD | $448 489.72 USD | $21.31 23.29 USD | $22.49 24.58 USD | $2.52B 2.75B USD | 0 | -$1.06 -1.1 USD | |
| Crinetics Pharmaceuticals, Inc. 6Z4.F | $25.8 28.2 USD |
-0.77
|
$2.42B 2.64B USD | $60 65.59 USD | $25.8 28.2 USD | $25.8 28.2 USD | $2.42B 2.64B USD | 0 | -$3.36 -3.6 USD | |
| Catalyst Pharmaceuticals, Inc. CN2.F | $18.9 20.66 USD |
-1.56
|
$2.31B 2.52B USD | $40 43.73 USD | $18.9 20.66 USD | $18.9 20.66 USD | $2.31B 2.52B USD | 13.79 | $1.37 1.5 USD | |
| Mirum Pharmaceuticals, Inc. 08D.F | $42.4 46.35 USD |
0
|
$2.13B 2.33B USD | $26 28.42 USD | $42.2 46.13 USD | $42.4 46.35 USD | $2.13B 2.33B USD | 0 | -$1.4 -1.5 USD | |
| ImmunityBio, Inc. 26CA.F | $2.4 2.62 USD |
+1.95
|
$2.12B 2.32B USD | $3K 3.28K USD | $2.4 2.62 USD | $2.4 2.62 USD | $2.12B 2.32B USD | 0 | -$0.52 -0.5 USD | |
| Xenon Pharmaceuticals Inc. XP0.F | $27.2 29.73 USD |
-1.45
|
$2.09B 2.28B USD | $10 10.93 USD | $27.2 29.73 USD | $27.2 29.73 USD | $2.09B 2.28B USD | 0 | -$2.8 -3.06 USD | |
| Everest Medicines Limited 6HN.F | $5.8 6.34 USD |
+3.57
|
$1.98B 2.17B USD | $12 13.12 USD | $5.8 6.34 USD | $5.8 6.34 USD | $1.98B 2.17B USD | 0 | -$0.39 -0.4 USD | |
| Ligand Pharmaceuticals Incorporated LGDN.F | $98.5 107.67 USD |
+2.07
|
$1.94B 2.12B USD | $20 21.86 USD | $98.5 107.67 USD | $98.5 107.67 USD | $1.94B 2.12B USD | 0 | -$6.44 -7.03 USD | |
| Apellis Pharmaceuticals, Inc. 1JK.F | $14.58 15.94 USD |
-0.34
|
$1.91B 2.09B USD | $680 743.33 USD | $14.58 15.94 USD | $14.58 15.94 USD | $1.91B 2.09B USD | 0 | -$1.57 -1.7 USD | |
| Arrowhead Pharmaceuticals, Inc. HDP1.F | $13.36 14.6 USD |
+1.37
|
$1.85B 2.03B USD | $80 87.45 USD | $13.36 14.6 USD | $13.36 14.6 USD | $1.85B 2.03B USD | 0 | -$1.1 -1.2 USD | |
| Vericel Corporation ATQP.F | $36.2 39.57 USD |
+0.56
|
$1.84B 2.01B USD | $130 142.11 USD | $36.2 39.57 USD | $36.2 39.57 USD | $1.84B 2.01B USD | 905.00 | $0.04 0.04 USD | |
| BioCryst Pharmaceuticals, Inc. BO1.F | $8.55 9.35 USD |
-1.25
|
$1.81B 1.98B USD | $100 109.31 USD | $8.36 9.14 USD | $8.55 9.35 USD | $1.81B 1.98B USD | 0 | -$0.22 -0.2 USD | |
| Veracyte, Inc. 12V.F | $22.8 24.92 USD |
0
|
$1.8B 1.97B USD | $1.17K 1.28K USD | $22.8 24.92 USD | $22.8 24.92 USD | $1.8B 1.97B USD | 61.62 | $0.37 0.4 USD | |
| Bavarian Nordic A/S BV3.F | $22.89 25.02 USD |
+4.14
|
$1.78B 1.95B USD | $722 789.24 USD | $22.36 24.44 USD | $22.89 25.02 USD | $1.78B 1.95B USD | 9.69 | $2.36 2.58 USD | |
| BB Biotech AG BBZA.F | $31.7 34.65 USD |
-1.09
|
$1.73B 1.9B USD | $75 81.99 USD | $31.7 34.65 USD | $32 34.98 USD | $1.73B 1.9B USD | 12.99 | $2.44 2.67 USD | |
| Denali Therapeutics Inc. 4DN.F | $11.73 12.82 USD |
-2.05
|
$1.7B 1.86B USD | $200 218.63 USD | $11.73 12.82 USD | $11.73 12.82 USD | $1.7B 1.86B USD | 0 | -$2.32 -2.5 USD | |
| Agios Pharmaceuticals, Inc. 8AP.F | $28.6 31.26 USD |
-3.38
|
$1.66B 1.81B USD | $54 59.03 USD | $28.6 31.26 USD | $28.6 31.26 USD | $1.66B 1.81B USD | 2.77 | $10.31 11.27 USD | |
| IDEAYA Biosciences, Inc. 30J.F | $18.5 20.22 USD |
-0.54
|
$1.62B 1.77B USD | $350 382.6 USD | $18.5 20.22 USD | $18.5 20.22 USD | $1.62B 1.77B USD | 0 | -$3.17 -3.4 USD | |
| Sarepta Therapeutics, Inc. AB3A.F | $16.26 17.77 USD |
-1.48
|
$1.6B 1.75B USD | $520 568.43 USD | $16.26 17.77 USD | $16.26 17.77 USD | $1.6B 1.75B USD | 0 | -$2.43 -2.6 USD | |
| Galapagos NV GXE.F | $23.5 25.69 USD |
+0.51
|
$1.58B 1.73B USD | $340 371.67 USD | $23.5 25.69 USD | $23.5 25.69 USD | $1.58B 1.73B USD | 0 | -$2.72 -2.9 USD | |
| Centessa Pharmaceuticals plc 260.F | $11.1 12.13 USD |
+4.72
|
$1.55B 1.7B USD | $0 0 USD | $11.1 12.13 USD | $11.1 12.13 USD | $1.55B 1.7B USD | 0 | -$1.67 -1.8 USD | |
|
没有最喜欢的股票
您还没有喜欢的股票，请将其添加到收藏夹以在此处查看 |
||||||||||